4.7 Article

Diverse intracellular pathogens activate type III interferon expression from peroxisomes

Journal

NATURE IMMUNOLOGY
Volume 15, Issue 8, Pages 717-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2915

Keywords

-

Categories

Funding

  1. US National Institutes of Health [AI093589, AI072955, P30 DK34854, CA159132]
  2. Burroughs Wellcome Fund
  3. Crohn's and Colitis Foundation of America
  4. Agence National de la Recherche (ANR project Mitopatho)
  5. Erwin Schrodinger Fellowship of the Austrian Science Fund (FWF)
  6. Herchel Smith Graduate Fellowship Program
  7. Massachusetts Institute of Technology-Boston Children's Hospital Collaborative grant
  8. European Research Council Advanced Grant [233348]
  9. Howard Hughes Medical Institute

Ask authors/readers for more resources

Type I interferon responses are considered the primary means by which viral infections are controlled in mammals. Despite this view, several pathogens activate antiviral responses in the absence of type I interferons. The mechanisms controlling type I interferon-independent responses are undefined. We found that RIG-I like receptors (RLRs) induce type III interferon expression in a variety of human cell types, and identified factors that differentially regulate expression of type I and type III interferons. We identified peroxisomes as a primary site of initiation of type III interferon expression, and revealed that the process of intestinal epithelial cell differentiation upregulates peroxisome biogenesis and promotes robust type III interferon responses in human cells. These findings highlight the importance of different intracellular organelles in specific innate immune responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available